SRDXSURMODICS INC

Nasdaq surmodics.com


$ 26.12 $ 0.10 (0.38 %)    

Thursday, 25-Apr-2024 15:56:25 EDT
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 26.17
$ 25.86
$ 0.00 x 0
$ 0.00 x 0
$ 25.35 - $ 26.12
$ 16.79 - $ 39.41
31,837
na
367.19M
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-01-2024 12-31-2023 10-Q
2 08-02-2023 06-30-2023 10-Q
3 04-26-2023 03-31-2023 10-Q
4 02-06-2023 12-31-2022 10-Q
5 11-23-2022 09-30-2022 10-K
6 07-27-2022 06-30-2022 10-Q
7 04-27-2022 03-31-2022 10-Q
8 02-04-2022 12-31-2021 10-Q
9 11-24-2021 09-30-2021 10-K
10 08-04-2021 06-30-2021 10-Q
11 04-28-2021 03-31-2021 10-Q
12 02-09-2021 12-31-2020 10-Q
13 12-02-2020 09-30-2020 10-K
14 08-05-2020 06-30-2020 10-Q
15 04-30-2020 03-31-2020 10-Q
16 02-07-2020 12-31-2019 10-Q
17 12-03-2019 09-30-2019 10-K
18 08-01-2019 06-30-2019 10-Q
19 05-03-2019 03-31-2019 10-Q
20 02-01-2019 12-31-2018 10-Q
21 11-30-2018 09-30-2018 10-K
22 08-06-2018 06-30-2018 10-Q
23 05-04-2018 03-31-2018 10-Q
24 02-08-2018 12-31-2017 10-Q
25 12-01-2017 09-30-2017 10-K
26 08-03-2017 06-30-2017 10-Q
27 04-28-2017 03-31-2017 10-Q
28 02-03-2017 12-31-2016 10-Q
29 12-02-2016 09-30-2016 10-K
30 07-29-2016 06-30-2016 10-Q
31 05-10-2016 03-31-2016 10-Q
32 02-05-2016 12-31-2015 10-Q
33 12-04-2015 09-30-2015 10-K
34 08-06-2015 06-30-2015 10-Q
35 05-05-2015 03-31-2015 10-Q
36 02-04-2015 12-31-2014 10-Q
37 12-05-2014 09-30-2014 10-K
38 08-01-2014 06-30-2014 10-Q
39 05-08-2014 03-31-2014 10-Q
40 02-04-2014 12-31-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-surmodics-maintains-47-price-target

Needham analyst Mike Matson reiterates Surmodics (NASDAQ:SRDX) with a Buy and maintains $47 price target.

 why-ch-robinson-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

 needham-maintains-buy-on-surmodics-raises-price-target-to-47

Needham analyst Mike Matson maintains Surmodics (NASDAQ:SRDX) with a Buy and raises the price target from $44 to $47.

 surmodics-q1-adjusted-eps-000-may-not-be-comparable-to-030-estimate-sales-3055m-beat-2964m-estimate

Surmodics (NASDAQ:SRDX) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.30) by ...

 earnings-scheduled-for-february-1-2024

Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NY...

 a-preview-of-surmodicss-earnings
A Preview Of Surmodics's Earnings
01/31/2024 19:01:41

 surmodics-announced-early-clinical-use-of-the-companys-pounce-lp-low-profile-thrombectomy-system

The Pounce LP Thrombectomy System, which received U.S. Food and Drug Administration (FDA) clearance in June 2023, is currently ...

 barrington-research-maintains-outperform-on-surmodics-raises-price-target-to-71

Barrington Research analyst Michael Petusky maintains Surmodics (NASDAQ:SRDX) with a Outperform and raises the price target ...

 needham-maintains-buy-on-surmodics-lowers-price-target-to-44

Needham analyst Mike Matson maintains Surmodics (NASDAQ:SRDX) with a Buy and lowers the price target from $50 to $44.

 surmodics-q4-adj-eps-053-compared-to-026-in-the-prior-year-period-sales-2797m-beat-2627m-estimate

Surmodics (NASDAQ:SRDX) reported adjusted quarterly earnings of $0.53 per share. This is a 303.85 percent increase over losses ...

 earnings-scheduled-for-november-8-2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

 needham-reiterates-buy-on-surmodics-raises-price-target-to-50

Needham analyst Mike Matson reiterates Surmodics (NASDAQ:SRDX) with a Buy and raises the price target from $36 to $50.

 earnings-scheduled-for-august-2-2023

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earn...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION